# US Mammography Market

> US Mammography Market Research Report: Size, Share, Trend Analysis By Types (Screening Mammography, Diagnostic Mammography), By Technology (2-D Technology, 3-D Technology, Combination Technology), By Product (Digital Systems, Analog Systems, Breast Tomosynthesis, Film Screen Systems, Others) and By End-User (Hospitals, Specialty Clinics, Research Institutes, Diagnostic Center, Others) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 9.25%
- **2024:** $ 730.73 Million
- **2025:** $ 798.32 Million
- **2035:** $ 1,934.12 Million
- **Key Players:** Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), Philips (NL), Fujifilm (JP), Canon Medical Systems (JP), Carestream Health (US), Agfa HealthCare (BE), Konica Minolta (JP)

**Report ID:** MRFR/MED/16442-HCR · **Pages:** 100 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** July 20, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-mammography-market-17970

---

## Market Summary

## **US Mammography Market Overview**

As per MRFR analysis, the US Mammography Market Size was estimated at 668.28 (USD Million) in 2023. The US Mammography Market Industry is expected to grow from 730.1 (USD Million) in 2024 to 1,800 (USD Million) by 2035. The US Mammography Market CAGR (growth rate) is expected to be around 8.549% during the forecast period (2025 - 2035).

### **Key US Mammography Market Trends Highlighted**

The US mammography market is witnessing several important trends driven by advancements in technology, increasing awareness of breast cancer, and regulatory changes. A significant market driver is the rising incidence of breast cancer in the US, which has led to heightened screening initiatives and improved accessibility for women. Government programs and healthcare policies are actively promoting regular screenings, particularly in underserved communities. The introduction of digital mammography and tomosynthesis has enhanced diagnostic accuracy, making it easier for healthcare providers to detect abnormalities at earlier stages.

These technological advancements are increasingly being adopted across hospitals and outpatient facilities, creating a more efficient screening process. There are also valuable opportunities in the US mammography market with the push toward personalized healthcare. Patients are becoming more engaged in their health management, leading to a demand for tailored screening processes based on individual risk factors. This shift presents an opportunity for healthcare providers to develop patient-centered approaches, enhancing the overall experience while improving detection rates. Another opportunity lies in the integration of artificial intelligence (AI) into mammography.

AI-assisted readings can provide valuable support for radiologists, reducing workload and potentially improving outcomes. Recent trends include a growing emphasis on patient education and outreach programs aimed at increasing participation in routine screenings. Social media campaigns and community partnerships are expanding awareness around the importance of early detection, targeting diverse demographic groups to address disparities in breast cancer outcomes. As the healthcare landscape evolves, the US mammography market continues to adapt, focusing on innovation and improved patient outcomes.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **US Mammography Market Drivers**

#### **Increasing Incidence of Breast Cancer**

The rising incidence of breast cancer is a significant driver for the US Mammography Market Industry. According to the American Cancer Society, it is estimated that around 268,600 new cases of invasive breast cancer will be diagnosed in women in the United States in 2021 alone. This alarming statistic highlights the need for enhanced screening, driving the demand for mammography services. The United States Preventive Services Task Force (USPSTF) recommends routine mammography screening starting at age 40, further influencing the market growth.

As awareness surrounding breast cancer increases and more women seek early detection measures, the demand for mammography services is likely to grow, supporting the upward trajectory of the US Mammography Market Industry.

#### **Advancements in Mammography Technology**

Technological advancements in mammography, such as the adoption of digital mammography systems and 3D tomosynthesis, significantly propel the US Mammography Market Industry forward. These innovations have improved the accuracy and reliability of breast cancer screenings, making it easier for radiologists to detect abnormalities. A report by the FDA noted that the use of digital systems has led to a decrease in false positives and improved the rate of cancer detection.

As healthcare facilities in the United States increasingly adopt cutting-edge technologies to enhance patient outcomes, the demand for updated mammography equipment will inevitably rise, further driving the growth of the US Mammography Market Industry.

#### **Government Initiatives and Funding**

Government initiatives and funding to promote breast cancer awareness and screening programs significantly contribute to the growth of the US Mammography Market Industry. Programs funded by the Centers for Disease Control and Prevention (CDC) and the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) have increased access to mammography for underserved populations. The CDC's funding of approximately $213 million supports screening and diagnostic services for low-income women across the nation. Such initiatives not only foster awareness but also improve access to essential mammography services, making it a crucial driver for the US Mammography Market.

#### **Growing Population of Aging Women**

The growing population of aging women in the United States presents a favorable scenario for the US Mammography Market Industry. According to data from the United States Census Bureau, the female population aged 65 and older is projected to reach 29 million by 2030, representing a substantial increase from previous years. 
This demographic trend aligns with the higher incidence rates of breast cancer among older women, necessitating regular mammography screenings. As this population segment continues to grow, the demand for mammography services will likely increase, driving market growth and reinforcing the importance of the US Mammography Market Industry.

### **US Mammography Market Segment Insights**

#### **Mammography Market Type Insights**

The US Mammography Market segmentation under the Type category showcases a critical distinction between Screening Mammography and Diagnostic Mammography, both of which play essential roles in breast cancer detection and management within the healthcare system. Screening Mammography serves as a preventive measure primarily aimed at women who do not exhibit symptoms of breast cancer, typically recommended for women aged 40 and above. This segment is crucial for early detection since timely diagnosis can significantly increase survival rates and lead to less aggressive treatment options.

Annual screening programs have been credited with reducing breast cancer mortality, thereby reflecting their importance in public health initiatives. The US has implemented various campaigns to promote regular screenings, fostering an environment that encourages women to utilize mammography services as part of their healthcare routine. On the other hand, Diagnostic Mammography is utilized when breast abnormalities or symptoms such as lumps or discharge are present. This type of mammography is imperative for providing a more detailed examination of breast tissue and often involves further imaging procedures if abnormalities are detected.

The ability to accurately diagnose potential issues using this modality is critical to guiding subsequent treatment and management strategies. Moreover, as technological advancements continue to evolve within this sector, innovations such as 3D mammography have emerged, providing enhanced imaging capabilities that improve diagnosis accuracy, thereby solidifying the significance of this segment. Both segments significantly contribute to the US Mammography Market, driven by increasing breast cancer incidences and growing awareness of the importance of early detection. The national push for preventive healthcare coupled with advances in imaging technologies and methodologies collectively propel market growth.

However, challenges such as disparities in access to mammography services based on geographical location or socioeconomic status underscore the importance of addressing barriers to facilitate greater patient access to quality care. Overall, educating the population about the value of both Screening and Diagnostic Mammography will be vital as the market continues evolving, ensuring that effective solutions are readily available to address the pressing need for breast cancer detection and management nationwide.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

#### **Mammography Market Technology Insights**

The Technology segment of the US Mammography Market showcases significant evolution and development aimed at enhancing breast cancer detection and diagnosis. Among the various technologies available, 2-D Technology remains foundational and is widely utilized due to its established methodology and cost-effectiveness, allowing for vast accessibility in numerous healthcare settings. Conversely, 3-D Technology, also known as digital breast tomosynthesis, is gaining traction for its ability to provide more detailed images, reducing false-positive rates and allowing for earlier detection of anomalies.

This advancement is particularly vital as breast cancer statistics show that 1 in 8 women in the US will develop invasive breast cancer during their lifetime. Combination Technology incorporates both 2-D and 3-D imaging, offering clinicians a comprehensive view that supports accurate assessments; this hybrid approach is becoming increasingly popular due to its diagnostic accuracy. As advancements in mammography technology continue to develop, these methods are expected to play a pivotal role in improving patient outcomes and shaping future screening protocols in the US, driven by ongoing investment in Research and Development across the healthcare sector.

#### **Mammography Market Product Insights**

The US Mammography Market is witnessing significant advancements within its Product segment, encompassing a range of technologies essential for effective breast cancer screening and diagnosis. Digital Systems have transformed imaging practices, providing higher accuracy and faster results, which enhances patient outcomes. Analog Systems, while less prevalent, continue to serve important roles in certain facilities, demonstrating reliability in established practices. Breast Tomosynthesis is gaining traction due to its ability to produce 3D images, thereby improving detection rates and minimizing false positives, making it a critical aspect of contemporary breast imaging solutions.

Film Screen Systems still find applications, especially in facilities transitioning to more advanced technologies. The "Others" category encompasses emerging technologies and solutions that address specific needs in breast health. The ongoing innovations and improvements within these segments are driven by the demand for early detection and the rising incidence of breast cancer in the US, making the US Mammography Market vital for public health initiatives. As the market continues to evolve, advancements across these diverse Product segments will play a key role in shaping the future landscape of mammography services.

#### **Mammography Market End-User Insights**

The End-User segment in the US Mammography Market plays a crucial role in determining market dynamics and trends. Hospitals dominate this segment due to their extensive resources and capabilities to integrate advanced mammography systems, while Specialty Clinics focus on providing targeted breast health services, capitalizing on growing awareness among women. Research Institutes contribute significantly to innovation and the development of cutting-edge technologies, facilitating improved diagnostic accuracy. Diagnostic Centers are vital as they offer comprehensive screening and detection services, attracting a significant number of patients for routine check-ups.

The Other segment encompasses various healthcare providers that also cater to niche markets, thereby enhancing service accessibility. The increasing prevalence of breast cancer, along with initiatives aimed at raising awareness of regular screenings, is expected to drive demand across all components of this sector. Additionally, technological advancements and investments in healthcare infrastructure continue to bolster the US Mammography Market, positioning it for sustained growth in the coming years.

### **US Mammography Market Key Players and Competitive Insights**

The US Mammography Market has witnessed significant advancements and competition, characterized by an array of innovative technologies and a growing focus on early detection of breast cancer. Companies in this sector are continually refining their imaging modalities, which includes digital mammography and 3D tomosynthesis, as well as supplementing their offerings with advanced artificial intelligence for improved accuracy in diagnosing conditions. The competitive landscape is shaped by numerous vendors striving to enhance their market share through mergers and acquisitions, collaboration with healthcare institutions, and expanding their distribution networks to ensure broader access to their services.

A deep understanding of the industry's regulatory environment coupled with consumer preferences and evolving healthcare policies shapes the strategic moves of players in this dynamic market.

Hologic is recognized as a prominent leader in the US Mammography Market, characterized by its unwavering commitment to women's health. The company specializes in developing and manufacturing state-of-the-art breast imaging equipment that allows for high-quality diagnostic outcomes, particularly through their advanced 3D Helical Mammography technology. Hologic's strong presence in the US is bolstered by its focus on innovation and the development of products that integrate seamlessly into breast cancer screening programs. The company has established a reputation for not only producing reliable imaging systems but also for providing comprehensive support and training, which enhances the operational efficiency of healthcare providers.

Strengthened by a robust portfolio of patents and a reputation for quality, Hologic maintains a competitive edge while advocating for improved standards in breast cancer detection and imaging technology.

Konica Minolta is a noteworthy player within the US Mammography Market, excelling in the realm of advanced imaging and diagnostic solutions. The company offers a suite of products, including digital mammography systems that prioritize patient comfort and high-resolution imaging for more accurate analyses. With a dedicated focus on innovation, Konica Minolta has carved out a strong niche in the market through its commitment to seamless integration of its technologies into existing healthcare systems. Their strengths lie in developing user-friendly platforms that streamline workflows and enhance precision in diagnosis.

The company's strategy is often complemented by strategic mergers and collaborations that extend their capabilities and market reach. These initiatives not only facilitate the introduction of cutting-edge technology but also solidify Konica Minolta's position as a significant contributor to early breast cancer detection solutions in the United States, indicating a thriving presence in this competitive landscape.

### **Key Companies in the US Mammography Market Include**

- **[Hologic](https://www.hologic.com/hologic-products/breast-health-solutions/selenia-dimensions-mammography-system)**
- Konica Minolta
- Agfa Healthcare
- MRI Interventions
- American Radiology Services
- Radiology Partners
- Fujifilm Medical Systems
- Samsung Medison
- RadNet
- Elekta
- Siemens Healthineers
- Philips
- Canon Medical Systems
- General Electric
- Carestream Health

### **US Mammography Market Industry Developments**

The US Mammography Market has seen significant developments recently, particularly with companies like Hologic, Siemens Healthineers, and Agfa Healthcare leading the way in advancing imaging technologies. In August 2023, Hologic announced new initiatives aimed at improving breast cancer detection rates through innovative mammography techniques and enhancements to their existing product lines. Meanwhile, Siemens Healthineers unveiled artificial intelligence-powered solutions designed to streamline mammography workflows, making them more efficient and accurate. In terms of mergers and acquisitions, Konica Minolta acquired a predictive analytics firm in July 2023, enhancing its service offerings in imaging technology.

Market valuations have increased, particularly due to high demand for early detection methods which are linked to rising breast cancer awareness. As of September 2023, Radiology Partners announced an expansion of its network, focusing on providing comprehensive radiology services amid a growing emphasis on preventive healthcare measures. Over the past few years, the trend towards integrating AI and machine learning in mammography has accelerated, particularly following regulatory approvals in early 2022, which has significantly impacted operational efficiencies and patient outcomes in the US healthcare landscape.

### **US Mammography Market Segmentation Insights**

#### **Mammography Market Type Outlook**

- Screening Mammography
- Diagnostic Mammography

#### **Mammography Market Technology Outlook**

- 2-D Technology
- 3-D Technology
- Combination Technology

#### **Mammography Market Product Outlook**

- Digital Systems
- Analog Systems
- Breast Tomosynthesis
- Film Screen Systems
- Others

#### **Mammography Market End-User Outlook**

- Hospitals
- Specialty Clinics
- Research Institutes
- Diagnostic Center
- Others

## Market Drivers

### Rising Incidence of Breast Cancer

The increasing incidence of breast cancer in the US is a primary driver for the mammography market. According to the American Cancer Society, approximately 1 in 8 women will develop invasive breast cancer during their lifetime. This alarming statistic underscores the necessity for regular screening, which is facilitated by advancements in mammography technology. As awareness of breast cancer risks grows, more women are likely to seek mammography services, thereby propelling market growth. The mammography market is projected to expand as healthcare providers emphasize early detection strategies, which are crucial for improving survival rates. Furthermore, the rising number of breast cancer cases is expected to lead to increased funding for screening programs, further stimulating demand for mammography services.

### Government Initiatives and Funding

Government initiatives aimed at improving breast cancer screening rates significantly influence the mammography market. Programs such as the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provide funding for low-income women to access mammography services. These initiatives not only enhance accessibility but also raise awareness about the importance of regular screenings. In recent years, federal and state governments have allocated substantial resources to support these programs, which has resulted in increased participation rates in mammography screenings. The financial backing from government sources is likely to continue, fostering an environment conducive to growth in the mammography market. As more women gain access to these essential services, the overall demand for mammography is expected to rise.

### Technological Innovations in Imaging

Technological innovations in imaging techniques are transforming the mammography market. The introduction of 3D mammography, or digital breast tomosynthesis, has shown to improve detection rates of breast cancer, particularly in women with dense breast tissue. Studies indicate that 3D mammography can increase cancer detection rates by up to 40% compared to traditional 2D mammography. As healthcare facilities adopt these advanced technologies, the quality of screening improves, leading to higher patient satisfaction and increased screening rates. Furthermore, the integration of advanced imaging technologies is likely to attract more patients, thereby driving growth in the mammography market. The ongoing research and development in imaging modalities suggest a promising future for enhanced mammography services.

### Growing Focus on Preventive Healthcare

The growing focus on preventive healthcare is a significant driver for the mammography market. As healthcare systems shift towards preventive measures, the emphasis on early detection of diseases, including breast cancer, becomes paramount. This trend is reflected in the increasing number of health campaigns promoting regular mammography screenings. Additionally, insurance providers are increasingly covering preventive services, which encourages women to participate in regular screenings. The proactive approach to healthcare is likely to result in a higher demand for mammography services, as more women recognize the importance of early detection. This cultural shift towards preventive care is expected to sustain growth in the mammography market, as it aligns with broader public health goals.

### Aging Population and Increased Screening

The aging population in the US is a crucial factor influencing the mammography market. As women age, their risk of developing breast cancer increases, leading to a higher demand for screening services. The US Census Bureau projects that by 2030, the number of women aged 65 and older will reach approximately 20 million. This demographic shift is likely to result in a surge in demand for mammography services, as older women are encouraged to undergo regular screenings. Healthcare providers are adapting to this trend by offering more accessible and tailored mammography services for older populations. Consequently, the aging demographic is expected to play a pivotal role in driving growth within the mammography market, as the need for effective screening solutions becomes increasingly critical.

## Future Outlook

The [Mammography Market](https://www.marketresearchfuture.com/reports/mammography-market-2443) is projected to grow at a 9.25% CAGR from 2025 to 2035, driven by technological advancements, increasing awareness, and rising healthcare expenditures.

**New opportunities:**

- Development of AI-driven diagnostic tools for enhanced accuracy Expansion of mobile mammography units to underserved areas Partnerships with telehealth platforms for remote consultations

By 2035, the mammography market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Screening Mammography (Largest) vs. Diagnostic Mammography (Fastest-Growing)

In the US mammography market, Screening Mammography holds a substantial market share, primarily driven by its pivotal role in early detection and preventive healthcare. This segment is widely adopted due to its effectiveness in identifying breast cancer among asymptomatic women. On the other hand, Diagnostic Mammography, while smaller in share, is gaining traction as it serves a crucial function in evaluating abnormalities detected during screening, leading to increased utilization rates.

The growth of the Diagnostic Mammography segment can be attributed to rising awareness about breast cancer and advancements in imaging technologies. Technological innovations within this segment enhance diagnostic accuracy and reduce patient discomfort, contributing to its fastest growth. Additionally, the increasing prevalence of breast cancer and a growing emphasis on personalized healthcare drive the demand for both mammography types, ensuring a robust future for the market.

Screening Mammography (Dominant) vs. Diagnostic Mammography (Emerging)

Screening Mammography is recognized as the dominant segment within the US mammography market, providing essential services for early breast cancer detection. It is characterized by routine examinations aimed at women who are asymptomatic, thus allowing early intervention when cancer is most treatable. In contrast, Diagnostic Mammography is considered an emerging segment focused on evaluating patients with symptoms or abnormal screening results. This segment seeks to provide more detailed imaging and is marked by a growing preference among clinicians for thorough examinations. Factors such as increasing screening rates and better insurance coverage further bolster the position of both segments, illustrating their vital roles in comprehensive breast health management.

### By Technology: 3-D Technology (Largest) vs. Combination Technology (Fastest-Growing)

In the US mammography market, the distribution of market share among the technology segments reveals that 3-D Technology is the largest segment, capturing a significant portion of the market. This technology has gained widespread acceptance due to its enhanced imaging capabilities, providing clearer and more accurate results compared to traditional methods. Meanwhile, Combination Technology is emerging rapidly, appealing to healthcare providers looking to offer comprehensive diagnostic solutions. 

Growth trends indicate that the demand for advanced imaging technologies in the US mammography market is being driven by increasing awareness of breast cancer screening and the benefits of early detection. The adoption of 3-D Technology is bolstered by its improved diagnostic accuracy, while Combination Technology is gaining traction as providers recognize the advantages of integrated systems that offer both 2-D and 3-D imaging. These trends suggest a competitive landscape characterized by continual technology advancement and innovation.

Technology: 3-D Technology (Dominant) vs. Combination Technology (Emerging)

3-D Technology is regarded as the dominant force in the US mammography market, primarily due to its ability to produce high-resolution images that facilitate better detection of abnormalities. This technology allows for the reconstruction of breast images in multiple dimensions, significantly reducing false positives and unnecessary biopsies. On the other hand, Combination Technology is an emerging segment poised for rapid growth, as it combines the strengths of both 2-D and 3-D imaging. This integrated approach provides clinicians with comprehensive diagnostic capabilities, making it an attractive option for healthcare facilities. As technology continues to evolve, the market positioning of these segments will be crucial for meeting the increasing demand for advanced breast cancer screening technologies.

### By Product: Digital Systems (Largest) vs. Breast Tomosynthesis (Fastest-Growing)

The US mammography market is witnessing a diverse distribution among product segments. Digital Systems account for a significant share, being the largest due to their advanced imaging capabilities and ease of integration into modern healthcare systems. In contrast, Analog Systems, while traditional, have seen a decline as healthcare providers lean towards more innovative solutions like Breast Tomosynthesis, which is gaining ground thanks to its ability to provide 3D imaging and improved detection rates.

Growth trends indicate a shift towards more sophisticated technologies as healthcare demands evolve. Breast Tomosynthesis is rapidly becoming the fastest-growing segment, driven by increasing awareness of breast cancer and the need for accurate diagnostics. Factors such as technological advancements, higher investment in healthcare infrastructure, and government initiatives supporting early detection are propelling the growth of this segment, indicating a promising future in the US mammography market.

Digital Systems (Dominant) vs. Breast Tomosynthesis (Emerging)

Digital Systems have established themselves as the dominant force in the US mammography market, characterized by their superior imaging quality and efficient workflow enhancements. These systems offer faster diagnosis and improved patient experiences, making them a preferred choice among healthcare providers. In contrast, Breast Tomosynthesis is emerging as a revolutionary option, leveraging 3D imaging to enhance detection and reduce false positives. This technology is particularly appealing in densely glandular breast tissue, where traditional 2D imaging may fall short. As awareness of breast health increases, Breast Tomosynthesis is expected to carve a significant niche for itself, attracting investments and adoption from institutions aiming to provide cutting-edge diagnostic services.

### By End-User: Hospitals (Largest) vs. Specialty Clinics (Fastest-Growing)

In the US mammography market, the distribution of market share among end-user segments reveals that hospitals dominate the landscape. This dominance is attributed to their extensive resources, comprehensive services, and the capacity to cater to a large patient base. Specialty clinics, while holding a smaller share, are gaining traction due to their specialized services and patient-centered approach, which appeals to specific demographics seeking personalized care.

Growth trends in the end-user segment are significantly influenced by increasing awareness of the importance of early detection and screening among women. As preventive healthcare takes precedence, both hospitals and specialty clinics are adapting, with hospitals expanding their services and specialty clinics emerging rapidly to meet the rising demand. Research institutes and diagnostic centers also play a crucial role, often collaborating with hospitals to enhance imaging technologies and patient outcomes.

Hospitals (Dominant) vs. Specialty Clinics (Emerging)

Hospitals in the US mammography market are characterized by their comprehensive capabilities and broad service offerings, enabling them to conduct a large volume of screenings and diagnostics. Their ability to integrate advanced imaging technologies with patient care solidifies their position as the dominant force. Conversely, specialty clinics, although emerging, are redefining patient experiences by providing focused services like tailored consultations and rapid turnaround times for results. This specialization attracts a growing clientele who prioritize convenience and individualized attention. As these clinics continue to innovate and collaborate with larger healthcare systems, they are expected to gain a more substantial foothold, further diversifying the market.

## Competitive Benchmarking

The mammography market exhibits a dynamic competitive landscape characterized by rapid technological advancements and a growing emphasis on early detection of breast cancer. Key players such as Hologic (US), Siemens Healthineers (DE), and GE Healthcare (US) are at the forefront, leveraging innovation and strategic partnerships to enhance their market positions. Hologic (US) focuses on developing advanced imaging technologies, while Siemens Healthineers (DE) emphasizes integrating AI into their systems to improve diagnostic accuracy. GE Healthcare (US) is also investing in digital solutions to streamline workflows, indicating a collective shift towards technology-driven healthcare solutions.The market structure appears moderately fragmented, with several players vying for market share. Companies are increasingly localizing manufacturing and optimizing supply chains to enhance operational efficiency. This strategy not only reduces costs but also allows for quicker response times to market demands. The presence of multiple key players contributes to a competitive environment where innovation and customer-centric solutions are paramount.
In October Hologic (US) announced the launch of its latest 3D mammography system, which incorporates advanced AI algorithms to improve detection rates. This strategic move is likely to bolster Hologic's market share by addressing the growing demand for more accurate and efficient screening methods. The integration of AI into their systems may also enhance the overall patient experience, positioning Hologic as a leader in technological innovation within the sector.
In September Siemens Healthineers (DE) expanded its partnership with a leading healthcare provider to implement a comprehensive digital mammography solution across multiple facilities. This collaboration underscores Siemens' commitment to enhancing patient care through technology. By integrating their advanced imaging systems with the healthcare provider's infrastructure, Siemens Healthineers (DE) is likely to improve diagnostic workflows and patient outcomes, further solidifying its competitive edge.
In August GE Healthcare (US) unveiled a new initiative aimed at increasing access to mammography services in underserved communities. This initiative not only reflects GE's commitment to social responsibility but also positions the company favorably in a market increasingly focused on equitable healthcare access. By addressing disparities in healthcare delivery, GE Healthcare (US) may enhance its brand reputation and foster loyalty among healthcare providers and patients alike.
As of November the mammography market is witnessing trends such as digitalization, AI integration, and a heightened focus on sustainability. Strategic alliances among key players are shaping the competitive landscape, fostering innovation and collaboration. The shift from price-based competition to a focus on technological advancements and supply chain reliability is evident. Companies that prioritize innovation and customer-centric solutions are likely to thrive in this evolving market, suggesting a future where competitive differentiation hinges on the ability to adapt to emerging trends.

## Recent News & Developments

The US Mammography Market has seen significant developments recently, particularly with companies like Hologic, Siemens Healthineers, and Agfa Healthcare leading the way in advancing imaging technologies. In August 2023, Hologic announced new initiatives aimed at improving breast cancer detection rates through innovative mammography techniques and enhancements to their existing product lines. Meanwhile, Siemens Healthineers unveiled artificial intelligence-powered solutions designed to streamline mammography workflows, making them more efficient and accurate. In terms of mergers and acquisitions, Konica Minolta acquired a predictive analytics firm in July 2023, enhancing its service offerings in imaging technology.

Market valuations have increased, particularly due to high demand for early detection methods which are linked to rising breast cancer awareness. As of September 2023, Radiology Partners announced an expansion of its network, focusing on providing comprehensive radiology services amid a growing emphasis on preventive healthcare measures. Over the past few years, the trend towards integrating AI and machine learning in mammography has accelerated, particularly following regulatory approvals in early 2022, which has significantly impacted operational efficiencies and patient outcomes in the US healthcare landscape.

## Report Scope

| MARKET SIZE 2024 | 730.73(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 798.32(USD Million) |
| MARKET SIZE 2035 | 1934.12(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 9.25% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Hologic (US), Siemens Healthineers (DE), GE Healthcare (US), Philips (NL), Fujifilm (JP), Canon Medical Systems (JP), Carestream Health (US), Agfa HealthCare (BE), Konica Minolta (JP) |
| Segments Covered | Type, Technology, Product, End-User |
| Key Market Opportunities | Integration of artificial intelligence in mammography for enhanced diagnostic accuracy and efficiency. |
| Key Market Dynamics | Technological advancements in imaging techniques drive competitive dynamics within the mammography market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US mammography market in 2024?**
A: The overall market valuation was $730.73 Million in 2024.

**Q: What is the projected market valuation for the US mammography market by 2035?**
A: The projected valuation for 2035 is $1,934.12 Million.

**Q: What is the expected CAGR for the US mammography market during the forecast period 2025 - 2035?**
A: The expected CAGR for the US mammography market during the forecast period 2025 - 2035 is 9.25%.

**Q: Which companies are considered key players in the US mammography market?**
A: Key players in the market include Hologic, Siemens Healthineers, GE Healthcare, Philips, Fujifilm, Canon Medical Systems, Carestream Health, Agfa HealthCare, and Konica Minolta.

**Q: What are the main segments of the US mammography market?**
A: The main segments include Type, Technology, Product, and End-User.

**Q: How did the screening mammography segment perform in 2024?**
A: The screening mammography segment was valued at $400.0 Million in 2024.

**Q: What is the projected value of the 3-D technology segment by 2035?**
A: The projected value of the 3-D technology segment is $900.0 Million by 2035.

**Q: What was the market value for diagnostic centers in 2024?**
A: The market value for diagnostic centers was $200.0 Million in 2024.

**Q: How does the value of digital systems compare to analog systems in 2024?**
A: In 2024, digital systems were valued at $200.0 Million, whereas analog systems were valued at $150.0 Million.

**Q: What is the expected growth trend for specialty clinics in the US mammography market?**
A: The specialty clinics segment is projected to grow from $150.0 Million in 2024 to a higher valuation by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-mammography-market-17970*